|
Osteoporosis
|
|
|
Exemestane significantly decreases bone mineral density in healthy postmenopausal women who take it to reduce their risk of breast cancer, according to a study published online Feb. 7 in The Lancet Oncology. Two years of daily oral treatment with the steroidal aromatase inhibitor was found to... »
BALTIMORE – Levetiracetam had effects on bone mineral density and markers of bone turnover that were similar to those seen with the older antiepileptic drugs carbamazepine and sodium valproate in a 12-month, randomized, controlled trial of 84 patients with partial epilepsy. The finding was counter... »
SAN DIEGO – Teriparatide is gaining traction as an off-label therapy to speed fracture repair and promote healing of delayed union and nonunion fractures. At a session expressly devoted to anabolic agents for fracture repair at the annual meeting of the American Society for Bone and Mineral... »
Interested in being notified of new Osteoporosis news?
Click here to view our Osteoporosis RSS Feed.
| Feb 5 - 12 Departs Ft. Lauderdale, FL | Preventive Medicine |
| Feb 6 - 11 Dallas, TX | Society for Maternal-Fetal Medicine (SMFM): Annual Meeting (The Pregnancy Meeting) |
| Feb 6 - 10 Sarasota, FL | Rheumatology: Improving Primary Care Outcomes Through Diagnosis and Treatment |
| Feb 7 - 11 San Francisco, CA | American Academy of Orthopaedic Surgeons (AAOS): Annual Meeting |
| Feb 8 - 12 Naples, FL | Dermatology Foundation (DF): Clinical Symposia |
| Feb 8 - 11 Barcelona, | International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) |
| Feb 8 - 10 San Diego, CA | American Academy of Emergency Medicine (AAEM): Annual Scientific Assembly |
| Feb 9 - 11 New York, NY | Integrative Healthcare Symposium |
| Feb 9 - 11 New Orleans, LA | American Federation for Medical Research (AFMR): Southern Regional Meeting |
| Feb 12 - 15 Freiburg, | German Society for Thoracic and Cardiovascular Surgery: 41st Annual Meeting |